Joachim Lueddecke - Rhoen Klinikum First Deputy Chairman of the Supervisory Board
| RKAGY Stock | USD 6.05 0.00 0.00% |
Chairman
Mr. Joachim Lueddecke is First Deputy Chairman of the Supervisory Board of Rhoen Klinikum AG since February 10 2010. In addition he acts as Member of the Investment Strategy and Finance Committee Personal Affairs Committee as well as Mediation Committee of the Company. Previously Mr. Lueddecke served as Member of the Supervisory Board at RhoenKlinikum AG from December 31 2005 until February 10 2010. Moreover he is also active as Regional Director of ver.di and occupies the position of Deputy Chairman of the Board of Management at Klinikum Region Hannover. since 2010.
| Tenure | 14 years |
| Phone | 49 9771 65 0 |
| Web | https://www.rhoen-klinikum-ag.com |
Rhoen Klinikum Management Efficiency
The company has return on total asset (ROA) of 0.0114 % which means that it generated a profit of $0.0114 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0265 %, meaning that it generated $0.0265 on every $100 dollars invested by stockholders. Rhoen Klinikum's management efficiency ratios could be used to measure how well Rhoen Klinikum manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 10 records | CHAIRMAN Age | ||
| Leo Higdon | Encompass Health Corp | 74 | |
| Robert Adams | National HealthCare | 72 | |
| Jigang Sun | Concord Medical Services | 46 | |
| Jianyu Yang | Concord Medical Services | 53 | |
| Rocco Ortenzio | Select Medical Holdings | 91 | |
| Robert Ortenzio | Select Medical Holdings | 66 | |
| Henry Esber | InnovAge Holding Corp | 78 | |
| Joey Jacobs | Acadia Healthcare | 63 | |
| Bruce Shear | Acadia Healthcare | 62 | |
| Roy Christensen | The Ensign Group | 84 | |
Management Performance
| Return On Equity | 0.0265 | |||
| Return On Asset | 0.0114 |
Rhoen Klinikum AG Leadership Team
Elected by the shareholders, the Rhoen Klinikum's board of directors comprises two types of representatives: Rhoen Klinikum inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rhoen. The board's role is to monitor Rhoen Klinikum's management team and ensure that shareholders' interests are well served. Rhoen Klinikum's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rhoen Klinikum's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Katrin Vernau, Member of the Supervisory Board | ||
| Peter Berghoefer, Member of the Supervisory Board | ||
| Tobias Kaltenbach, Chief Board | ||
| Kai Klinger, Head of Investor Relations | ||
| Stefan Stranz, CFO Board | ||
| Klaus Hanschur, Member of the Supervisory Board | ||
| JensPeter Neumann, Member of the Management Board, CFO | ||
| Esther Walter, Head PR | ||
| Brigitte Mohn, Member of the Supervisory Board | ||
| Joachim Lueddecke, First Deputy Chairman of the Supervisory Board | ||
| Bjoern Borgmann, Member of the Supervisory Board | ||
| Meike Jaeger, Member of the Supervisory Board | ||
| Gerhard Ehninger, Member of the Supervisory Board | ||
| Pr Griewing, Chief Medical Officer and Member of Management Board | ||
| Christine Reissner, Member of the Supervisory Board | ||
| Annette Beller, Member of the Supervisory Board | ||
| Martin Menger, COO and Member of the Management Board | ||
| Oliver Salomon, Member of the Supervisory Board | ||
| Eugen Mnch, Chief Representative | ||
| Wolfgang Muendel, Second Deputy Chairman of the Supervisory Board | ||
| Michael Mendel, Member of the Supervisory Board | ||
| Reinhard Hartl, Member of the Supervisory Board | ||
| Sylvia Buehler, Member of the Supervisory Board | ||
| Jrg Demmler, Head Environment | ||
| Bernd Griewing, Member of the Management Board, Chief Medical Officer | ||
| FranzJosef Schmitz, Member of the Supervisory Board | ||
| Bettina Boettcher, Member of the Supervisory Board | ||
| Julian Schmitt, Head Treasury | ||
| Stephan Holzinger, Member of the Supervisory Board | ||
| Elke Pfeifer, Head Marketing | ||
| Stefan Haertel, Member of the Supervisory Board | ||
| Gunther Weiss, Member of the Management Board | ||
| Heinz Korte, Member of the Supervisory Board | ||
| Natascha Weihs, Member of the Supervisory Board | ||
| Harald Auner, Patient Division | ||
| Franz Mlynek, Divisional Investments | ||
| Ludwig Braun, Member of the Supervisory Board | ||
| Eugen Muench, Chairman of the Supervisory Board | ||
| Gunther MSc, COO Board | ||
| Martin Siebert, Chairman of Management Board and CEO | ||
| Helmut Buehner, Member of the Supervisory Board | ||
| Evelin Schiebel, Member of the Supervisory Board | ||
| Georg SchulzeZiehaus, First Deputy Chairman of the Supervisory Board |
Rhoen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Rhoen Klinikum a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0265 | |||
| Return On Asset | 0.0114 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 928.19 M | |||
| Shares Outstanding | 133.88 M | |||
| Price To Earning | 540.83 X | |||
| Price To Book | 0.68 X | |||
| Price To Sales | 0.66 X | |||
| Revenue | 1.4 B |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhoen Klinikum AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Rhoen Klinikum AG information on this page should be used as a complementary analysis to other Rhoen Klinikum's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Rhoen Pink Sheet analysis
When running Rhoen Klinikum's price analysis, check to measure Rhoen Klinikum's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rhoen Klinikum is operating at the current time. Most of Rhoen Klinikum's value examination focuses on studying past and present price action to predict the probability of Rhoen Klinikum's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rhoen Klinikum's price. Additionally, you may evaluate how the addition of Rhoen Klinikum to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets |